Full Press Release Details
TORONTO and CAMBRIDGE, Mass., Sept. 19, 2017 (GLOBE NEWSWIRE) -- ERN UK
PMN
ProMIS Neurosciences Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer’s Disease
Key Takeaway: TORONTO and CAMBRIDGE, Mass., Sept. 19, 2017 (GLOBE NEWSWIRE) -- ERN UK